Corinne Noyes - Feb 12, 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role: SVP of Commercial Strategy and Market Development Exhibit 24 - Power of Attorney
Signature: /s/ Jason Cavalier, Attorney-in-Fact for Corinne Noyes
Stock symbol: LYRA
Transactions as of: Feb 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/15/2022, 08:31 PM
Next filing: Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LYRA	Stock Option	Award	$0	+32K		$0.00	32K	Feb 12, 2022	Common Stock	32K	$4.78	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.

Remarks:

SVP of Commercial Strategy and Market Development Exhibit 24 - Power of Attorney